Cardiovascular Associates of America

Cardiovascular Associates of America

Cardiovascular Associates of America operates as a physician practice management (PPM) platform, acquiring and partnering with independent cardiology practices across the United States. The company was formed in partnership with Webster Equity Partners, a healthcare-focused private equity firm with a track record of building specialist physician networks. The strategy targets the fragmented cardiology market, where solo and small-group practices face escalating overhead, declining reimbursement, and limited negotiating power with large hospital systems and payors. By aggregating these practices, CVA USA creates economies of scale in billing, procurement, compliance, and technology while preserving physician clinical autonomy and local brand identity. The platform deploys capital through majority acquisitions of established cardiology groups, typically leaving a material equity stake with the founding physicians to maintain alignment. The model spans general cardiology, interventional cardiology, and electrophysiology, with ancillary service lines in imaging, vascular medicine, and ambulatory surgical centers. Known platform practices operate across the Sun Belt and Midwest, with a geographic concentration in states such as Florida, Georgia, and Texas. The firm provides a centralized management services organization (MSO) that handles revenue cycle management, payer contracting, and regulatory compliance — functions that independent practices often lack the scale to optimize. The firm is backed by Webster Equity Partners, which closed its fifth fund at $875 million in 2023 and has historically targeted healthcare services buyouts. The exact deployment figure and total practice count for Cardiovascular Associates of America remain undisclosed. The platform competes directly with other cardiology roll-ups and hospital-employed physician networks, though no dedicated philanthropic or alternative investment vehicles have been identified as associated with the firm. CVA USA's distinction lies in its single-specialty focus: unlike multi-specialty PPM platforms that aggregate primary care, dermatology, and orthopedics under one holding company, the firm concentrates exclusively on cardiology. This vertical depth allows the MSO to develop clinical protocols, ancillary service lines, and outcome-based contracting that a generalist platform cannot replicate. Succession outcomes for retiring cardiologists — who often seek an exit when the next generation of partners lacks the capital to buy out their equity — serve as the primary structural demand driver for the platform's acquisition pipeline.